Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells

Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.
Тип документаJournal Article
Дата публикации2018-10-03
Название журналаJournal of Biomedical Materials Research - Part B Applied Biomaterials
Квартиль по SCImagoQ2
Квартиль по Web of ScienceQ3
Импакт-фактор 20213.41
ISSN15524973, 15524981
Biomedical Engineering
Краткое описание
Co-encapsulation of abiraterone acetate (AbrA) and docetaxel (Dtx) in polymeric nanoparticles as novel prototypes for prostate cancer treatment combining hormonal and chemotherapy was designed. Nanoparticles (NPs) composed of poly(dl-lactide-co-glycolide) (PLGA) were prepared by single-emulsion solvent evaporation technique and characterized in terms of morphology with atomic force microscopy and transmission electron microscopy. HPLC method for simultaneous determination of AbrA and Dtx encapsulation efficacy was developed. Also differential scanning calorimetry and Fourier-transform infrared spectroscopy were provided. To study the effectiveness of cellular internalization and distribution of NPs with AbrA and Dtx co-encapsulation (NP-AbrA/Dtx), a fluorescence microscopy was utilized. NPs prepared had size 256.3 ±9.4 nm and zeta potential -18.4 ±1.4 mV. Encapsulation efficacy for AbrA was 68.7% and for Dtx was 74.3%. NPs were able to control the AbrA and Dtx release within 24 h. The mathematical model of drug release was performed. The results obtained from confocal microscopy showed the effective accumulation of the NP-AbrA/Dtx in the cytoplasm of cells. Synthesized NPs possessed satisfactory parameters and a biphasic release profile, proceeding by the Fick diffusion mechanism, which provide prolonged release of the drugs and maintenance of their concentration. It was shown that NPs loaded with AbrA and Dtx exhibited a high cytotoxic activity on the LNCaP cell line, similar to the combination of free drugs of AbrA and Dtx, but in contrast to the combination of substances, had a synergistic mechanism of action. Our findings support the potential use of developed NPs in further in vivo studies. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1150-1158, 2019.
Пристатейные ссылки: 21
Цитируется в публикациях: 27
The docetaxel polymeric form and its antitumor activity
Nikolskaya E.D., Zhunina O.A., Yabbarov N.G., Tereshchenko O.G., Godovannyy A.V., Gukasova N.V., Severin E.S.
Q4 Russian Journal of Bioorganic Chemistry 2017 цитирований: 4
Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang W., Larsson M., Lee Y., Liu D., Chiou G.
Q1 European Journal of Pharmaceutics and Biopharmaceutics 2016 цитирований: 25
Phase 1b Study of Abiraterone Acetate Plus Prednisone and Docetaxel in Patients with Metastatic Castration-resistant Prostate Cancer.
Tagawa S.T., Posadas E.M., Bruce J., Lim E.A., Petrylak D.P., Peng W., Kheoh T., Maul S., Smit J.W., Gonzalez M.D., De Porre P., Tran N., Nanus D.M.
Q1 European Urology 2016 цитирований: 13
In situ-forming PLGA implants loaded with leuprolide acetate/β-cyclodextrin complexes: mathematical modelling and degradation
Rahimi M., Mobedi H., Behnamghader A.
Q2 Journal of Microencapsulation 2016 цитирований: 7
Effects of Size and Surface Charge of Polymeric Nanoparticles on in Vitro and in Vivo Applications
Sadat S.M., Jahan S.T., Haddadi A.
Journal of Biomaterials and Nanobiotechnology 2016 цитирований: 75
PLGA nanofibers improves the antitumoral effect of daunorubicin.
Guimarães P.P., Oliveira M.F., Gomes A.D., Gontijo S.M., Cortés M.E., Campos P.P., Viana C.T., Andrade S.P., Sinisterra R.D.
Q1 Colloids and Surfaces B: Biointerfaces 2015 цитирований: 23
Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins
Hamid Akash M.S., Rehman K., Chen S.
Q1 Polymer Reviews 2015 цитирований: 62
Combinatorial nanomedicines for colon cancer therapy.
Anitha A., Maya S., Sivaram A.J., Mony U., Jayakumar R.
Q1 Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2015 цитирований: 22
PLGA-based nanoparticles as cancer drug delivery systems.
Tabatabaei Mirakabad F.S., Nejati-Koshki K., Akbarzadeh A., Yamchi M.R., Milani M., Zarghami N., Zeighamian V., Rahimzadeh A., Alimohammadi S., Hanifehpour Y., Joo S.W.
Q3 Asian Pacific Journal of Cancer Prevention 2014 цитирований: 204
Open Access
Open access
Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy
Drake C.G., Sharma P., Gerritsen W.
Q1 Oncogene 2013 цитирований: 32
Open Access
Open access
Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: time to learn from past experiences.
Antonarakis E.S., Eisenberger M.A.
Q1 Journal of Clinical Oncology 2013 цитирований: 53
Poly(Lactic-Co-Glycolic Acid) Based Drug Delivery Devices For Tissue Engineering And Regenerative Medicine
Kerimoglu O., Alarcin E.
ANKEM Dergisi 2012 цитирований: 20
PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy
Pimple S., Manjappa A.S., Ukawala M., Murthy R.S.
Q1 Cancer Nanotechnology 2012 цитирований: 31
Open Access
Open access
Castration-resistant prostate cancer: systemic therapy in 2012
Maluf F., Smaletz O., Herchenhorn D.
Q2 Clinics 2012 цитирований: 22
Open Access
Open access
Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
Tsakalozou E., Eckman A.M., Bae Y.
Q4 Biochemistry Research International 2012 цитирований: 34
Open Access
Open access
1. Sokol M.B. и др. Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells // Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2018. Т. 107. № 4. С. 1150–1158.


DO - 10.1002/jbm.b.34208

UR -

TI - Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells

T2 - Journal of Biomedical Materials Research Part B: Applied Biomaterials

AU - Sokol, Mariya B.

AU - Nikolskaya, Elena D.

AU - Yabbarov, Nikita G.

AU - Zenin, Vladimir A.

AU - Faustova, Mariya R.

AU - Belov, Alexey V.

AU - Zhunina, Olga A.

AU - Mollaev, Murad D.

AU - Zabolotsky, Artur I.

AU - Tereshchenko, Oksana G.

AU - Severin, Eugen S.

PY - 2018

DA - 2018/10/03

PB - Wiley

SP - 1150-1158

IS - 4

VL - 107

SN - 1552-4973

SN - 1552-4981

ER -

BibTex |


doi = {10.1002/jbm.b.34208},

url = {},

year = 2018,

month = {oct},

publisher = {Wiley},

volume = {107},

number = {4},

pages = {1150--1158},

author = {Mariya B. Sokol and Elena D. Nikolskaya and Nikita G. Yabbarov and Vladimir A. Zenin and Mariya R. Faustova and Alexey V. Belov and Olga A. Zhunina and Murad D. Mollaev and Artur I. Zabolotsky and Oksana G. Tereshchenko and Eugen S. Severin},

title = {Development of novel {PLGA} nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells},

journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials}


Sokol, Mariya B. et al. “Development of Novel PLGA Nanoparticles with Co‐encapsulation of Docetaxel and Abiraterone Acetate for a Highly Efficient Delivery into Tumor Cells.” Journal of Biomedical Materials Research Part B: Applied Biomaterials 107.4 (2018): 1150–1158. Crossref. Web.